Neuro-inflammation is recognized as a major component of the pathology of AD, contributing to disease progression and neurodegeneration (87), in addition to aberrant Aβ protein deposition and hyperphosphorylation of tau protein. The gene discussed is MAPT; the disease is Alzheimer disease.